Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Editorial: similar risk of hepatocellular carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe. Authors' reply.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • Contributors:
      Physiopathologie du système immunitaire (Inserm U1223); Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité); Hôpital Cochin AP-HP; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP); Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP); Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU); CHU Saint-Antoine AP-HP; Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU); Inserm-ANRS, ANR, DGS and MSD, Janssen, Gilead, Abbvie, BMS, Roche; ANR-19-COHO-0002,Hepather (COHORTES),Therapeutic options for hepatitis B and/or C: a French nationwide cohort study(2019)
    • بيانات النشر:
      HAL CCSD
    • الموضوع:
      2021
    • نبذة مختصرة :
      International audience
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/33566398; PUBMED: 33566398
    • الرقم المعرف:
      10.1111/apt.16251
    • الدخول الالكتروني :
      https://hal.sorbonne-universite.fr/hal-03776245
      https://hal.sorbonne-universite.fr/hal-03776245v1/document
      https://hal.sorbonne-universite.fr/hal-03776245v1/file/10.1111_apt.16251.pdf
      https://doi.org/10.1111/apt.16251
    • Rights:
      http://creativecommons.org/licenses/by-nc/ ; info:eu-repo/semantics/OpenAccess
    • الرقم المعرف:
      edsbas.EA059F71